147 results on '"Silasi, D.-A."'
Search Results
2. A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
3. Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells
4. Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
5. Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo
6. Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
7. Does Use of Manipulator for Endometrial Cancer Surgery Lead to Increased Use of Adjuvant Therapy?
8. Intravenous Leiomyomatosis of the Uterus Extending into the Ovarian Vein
9. Robotic-Assisted Laparoscopic Hysterectomy in Large Fibroid Uterus, Tips and Techniques
10. Implementation of ERAS Perioperative Care Protocols for Gynecologic Surgery Shortens Hospital Admission Times, without Increasing Perioperative Risks
11. Robotic Resection of Symptomatic Parasitic Leiomyoma From the Obturator Fossa
12. Small Bowel Herniation Through a 5 mm Port Site After TAP Block: A Case Report and Demonstration of Technique for Confirming Bowel Viability
13. Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo
14. 735 - Robotic-Assisted Laparoscopic Hysterectomy in Large Fibroid Uterus, Tips and Techniques
15. 500 - Does Use of Manipulator for Endometrial Cancer Surgery Lead to Increased Use of Adjuvant Therapy?
16. 219 - Intravenous Leiomyomatosis of the Uterus Extending into the Ovarian Vein
17. The Effect of Vertical Versus Horizontal Vaginal Cuff Closure on Vaginal Length After Laparoscopic Hysterectomy
18. Identifying Risk Factors for Urinar y Retention After Hysterectomy for Leiomyoma
19. Robotic Hysterectomy for a Large Myomatous Uterus
20. 268 - Small Bowel Herniation Through a 5 mm Port Site After TAP Block: A Case Report and Demonstration of Technique for Confirming Bowel Viability
21. 17 - Robotic Resection of Symptomatic Parasitic Leiomyoma From the Obturator Fossa
22. 49 - Implementation of ERAS Perioperative Care Protocols for Gynecologic Surgery Shortens Hospital Admission Times, without Increasing Perioperative Risks
23. Risk Factors Associated with Urinary Retention after Robotic-Assisted Laparoscopic Hysterectomy
24. Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo
25. Abstract number 8: Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study
26. Impact of Body Mass Index on Outcomes of Endometrial Cancer Patients Undergoing Robotic-Assisted Staging and Analysis of Disease Recurrence
27. 7 Gy x 2 – An Effective Brachytherapy Regimen for Stage I-II Uterine Papillary Serous Carcinoma
28. Risk factors for omental metastasis in clinical stage I endometrial cancer: A meta-analysis
29. Class III beta-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel
30. Ovarian versus uterine serous carcinomas: Clinicopathologic and miRNA analysis
31. Institutional review of primary lymphoma of the female genital tract: A 32-year experience
32. Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
33. Adjuvant Carboplatin/Paclitaxel and Vaginal Brachytherapy for Locally Advanced Endometrial Cancer
34. Vaginal Cuff Dehiscence in Robotic Assisted Total Hysterectomies, Incidence, Prevention and Management
35. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy
36. Mammaglobin B (SCGB2A1)-specific CD8+ cytotoxic T lymphocytes (CTL) are highly effective in killing autologous chemotherapy resistant ovarian cancer cells: Implications for SCGB2A1 dendritic cell-based therapeutic vaccines
37. Constitutive proteasomal degradation of TWIST-1 in epithelial–ovarian cancer stem cells impacts differentiation and metastatic potential
38. Robotic-Assisted Gynecologic Surgery: Outcomes in Obese and Morbidly Obese Patients
39. Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab
40. The effect of intraperitoneal administration of clostridium perfringens enterotoxin on chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice.
41. A phase I clinical trial of the mTOR inhibitor everolimus in combination with oral topotecan for patients with recurrent and advanced endometrial cancer
42. Uterine serous papillary carcinomas overexpress human trophoblast cell surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody
43. Comparison between 150 Cases of Robotic vs. 150 Cases of Open Surgical Staging for Endometrial Cancer
44. Robotic Hysterectomy for an 18wk Size Uterus & a 20cm Right Adnexal Mass
45. hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma
46. Neoadjuvant carboplatin and paclitaxel (CP) chemotherapy (NACT) in patients (pts) with advancedstage (AS) epithelial ovarian cancer (EOC) compared with upfront surgical cytoreduction (USC) followed by CP.
47. Retrospective analysis of elderly patients (pts) with primary epithelial ovarian cancer (EOC) age 70 or older.
48. EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201) in chemotherapy-resistant ovarian cancer cell lines.
49. Cisplastin (C) and ifosfamide (I) chemotherapy with vaginal cuff brachytherapy (VCBT) for treatment of uterine carcinosarcoma.
50. HER-2/NEU overexpression in vulvar Paget disease: the Yale experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.